About Us

At Aphea.Bio, we discover, develop and commercialize innovative biological products for agriculture. As a research-driven company, we create biostimulant and biocontrol solutions that integrate seamlessly into conventional and organic crop protection and fertilizer markets.

Our solutions harness the power of biology to support healthier crops and more resilient farming systems. With versatility across the full spectrum of applications, from seed treatments to foliar sprays, we provide growers with safe, flexible and effective options that complement their existing practices and help protect yields while improving soil health.

We're not just creating products; we're advancing the science of sustainable agriculture. By working with natural biological processes, our innovations enable farmers to optimize productivity while supporting long-term soil health, biodiversity and ecosystem vitality.

Today, Aphea.Bio brings together a diverse team of passionate scientists and technical experts from across industry and academia, united by a shared mission: to transform agriculture through biological solutions that benefit growers, consumers and the planet.

Meet our Team

Leadership Team Strategic Advisory Board Board of Directors

Our History

  1. 65

    • Submission of first biocontrol regulatory dossier for VIRTUOSA™ in the US and EU
    • Silver medal awarded in first Ecovadis assessment

  2. 55 employees

    • registration and launch of first biostimulant, ACTIV by APHEA bio™
    • B-Corp certification
    • inauguration of pilot-scale production facility
    • closed Series C funding round with €70 million

  3. 43 employees

    • submission of first biostimulant dossier for market authorization
    • first commercial agreement signed

  4. 36 employees

    • full product development team established, ranging from Mode of Action, field trials, production & formulation to regulatory affairs
    • nomination of first commercial product candidates, proof of concept under field conditions

  5. 30 employees

    • field validated leads ready for product development track
    • established pipelines for bioinsecticides and bioherbicides
    • closed Series B funding round with €19.8 million

  6. 21 employees

    • exceeded 10k unique strains in the proprietary collection
    • first biofungicide field trials run
    • Facility expansion at Bioaccelerator

  7. 17 employees

    • biostimulant and biocontrol programs established with discovery pipelines (screening platforms) for wheat, climate chambers as well as automated phenotyping in greenhouse
    • first initial field trials for biostimulants
    • first IP filings submitted

  8. 10 employees

    • founded as VIB spin-off in July 2017
    • established greenhouse and lab facilities at Bioaccelerator in the Technologiepark Gent
    • closed Series A funding with €7.7 million